Literature DB >> 24973639

Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.

Bing Li1, Chufang Xie1, Xiaomin Lin1, Shao Bo Su2.   

Abstract

Behçet's disease (BD) is an autoimmune disease of unknown etiology. Interleukin-28A (IL-28A) promotes immune responses and may participate in the pathogenesis of autoimmune diseases. To examine the role of IL-28A in the pathogenesis of BD, we measured the expression of IFN-γ and IL-17 by IL-28A-stimulated peripheral blood mononuclear cells (PBMCs) from 19 patients with BD and 16 healthy individuals. We found that IFN-γ and IL-17 were undetectable in the sera from BD patients and control subjects. The mRNA expression and protein production of IFN-γ by IL-28A-stimulated PBMCs from BD patients were significantly increased compared to healthy individuals. No significant difference was observed in the mRNA expression and protein production of IL-17 by IL-28A-stimulated PBMCs between BD patients and normal individuals.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Behçet’s disease; Cytokine; IL-28A; PBMCs

Mesh:

Substances:

Year:  2014        PMID: 24973639     DOI: 10.1016/j.cellimm.2014.06.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status.

Authors:  Julia A Wisniewski; Lyndsey M Muehling; Jacob D Eccles; Brian J Capaldo; Rachana Agrawal; Debbie-Ann Shirley; James T Patrie; Lisa J Workman; Alexander J Schuyler; Monica G Lawrence; W Gerald Teague; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-09-20       Impact factor: 10.793

2.  Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.

Authors:  LingYun Yang; Ke Yi; HongJing Wang; YiQi Zhao; MingRong Xi
Journal:  Oncotarget       Date:  2016-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.